Published in Infect Immun on March 01, 1978
A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation. Prostaglandins (1976) 2.28
Studies with radioactive endotoxin. III. The effect of tolerance on the distribution of radioactivity after intravenous injection of Escherichia coli endotoxin labeled with Cr51. J Clin Invest (1958) 2.23
Studies of the effect bacterial endotoxins on rabbit leucocytes. II. Development of acquired resistance. J Exp Med (1953) 2.12
Distribution and clearance of circulating endotoxin. J Clin Invest (1963) 2.09
Accumulaon of macromolecular particles in the reticuloendothelial system (RES) mediated by platelet aggregation and disaggregation. Thromb Diath Haemorrh (1969) 1.38
Studies on distribution of Escherichia coli endotoxin in mice. Proc Soc Exp Biol Med (1959) 1.37
EFFECTS OF ENDOTOXIN AND NITROGEN MUSTARD ON LEUKOCYTE KINETICS. Blood (1965) 1.30
Clearance of endotoxin by platelets: role in increasing the accuracy of the Limulus gelation test and in combating experimental endotoxemia. Surgery (1973) 1.29
Tolerance to the granulocyte-releasing and colony-stimulating factor elevating effects of endotoxin. Blood (1975) 1.06
Inhibition of rabbit platelet aggregation and clot retraction by rabbit and human c-reactive proteins. Proc Soc Exp Biol Med (1977) 0.95
Effects of bacterial endotoxin on the fibrinolytic activity of normal human leukocytes. Blood (1971) 0.92
The role of platelets in the clearance of colloidal carbon from blood in rabbits: a light and electron microscope study. Pathology (1972) 0.90
The nature of endotoxin tolerance. Trans Am Clin Climatol Assoc (1975) 0.89
The role of platelet aggregation in the development of endotoxin shock. Br J Surg (1969) 0.87
The participation of the platelet in the vascular response to endotoxemia in the rabbit eye. Am J Pathol (1973) 0.87
Pathophysiology of Campylobacter enteritis. Microbiol Rev (1986) 4.94
Association of Aeromonas sobria with human infection. J Clin Microbiol (1981) 3.17
Reversible expression of flagella in Campylobacter jejuni. Infect Immun (1985) 2.92
Identification and characterization of two Campylobacter jejuni adhesins for cellular and mucous substrates. Infect Immun (1986) 2.85
The significance of hematologic abnormalities in patients with tuberculosis. Arch Intern Med (1970) 2.45
Simple adult rabbit model for Campylobacter jejuni enteritis. Infect Immun (1983) 2.02
Synergistic effect of bacteroides, Clostridium, Fusobacterium, anaerobic cocci, and aerobic bacteria on mortality and induction of subcutaneous abscesses in mice. J Infect Dis (1984) 1.94
Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock. J Clin Invest (1989) 1.87
Significance of flagella in colonization resistance of rabbits immunized with Campylobacter spp. Infect Immun (1991) 1.85
Antimicrobial prophylaxis for surgical wounds. Guidelines for clinical care. Arch Surg (1993) 1.64
Biphasic culture system for rapid Campylobacter cultivation. Appl Environ Microbiol (1983) 1.60
Hormonal responses to graded surgical stress. Arch Intern Med (1987) 1.59
Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection. Infect Immun (2001) 1.50
Nadolol to treat aggression and psychiatric symptomatology in chronic psychiatric inpatients: a double-blind, placebo-controlled study. J Clin Psychiatry (1992) 1.42
Intestinal mucus gel and secretory antibody are barriers to Campylobacter jejuni adherence to INT 407 cells. Infect Immun (1987) 1.42
Synergistic effects of cyclic AMP and nerve growth factor on neurite outgrowth and microtubule stability of PC12 cells. J Cell Biol (1985) 1.39
Pyrogenicity of granulocyte lysosomes. Am J Physiol (1966) 1.33
Safety and immunogenicity of a prototype oral whole-cell killed Campylobacter vaccine administered with a mucosal adjuvant in non-human primates. Vaccine (1995) 1.25
Mucosal and systemic immunity to Campylobacter jejuni in rabbits after gastric inoculation. Infect Immun (1988) 1.24
Modification, by aspirin and indomethacin, of the haemodynamic and prostaglandin releasing effects of E. coli endotoxin in the dog. Br J Pharmacol (1977) 1.23
Antibiotic and clavulanic acid treatment of subcutaneous abscesses caused by Bacteroides fragilis alone or in combination with aerobic bacteria. J Infect Dis (1983) 1.22
Pathogenicity of anaerobic gram-positive cocci. Infect Immun (1984) 1.19
The relationship between Fusobacterium species and other flora in mixed infection. J Med Microbiol (1986) 1.18
Campylobacter fetus ss. Jejuni, a newly recognized enteric pathogen: morphology and intestinal colonization. Scan Electron Microsc (1981) 1.18
Inhibition of lethality in endotoxin-challenged mice treated with zinc chloride. Infect Immun (1976) 1.17
Killed Campylobacter elicits immune response and protection when administered with an oral adjuvant. Vaccine (1993) 1.17
The effect of complement depletion on bacterial lipopolysaccharide (LPS)-induced hemodynamic and hematologic changes in the Rhesus monkey. Am J Pathol (1978) 1.14
Recovery of aerobic and anaerobic bacteria from irradiated mice. Infect Immun (1984) 1.12
Local dental anesthesia with epinephrine. Minimal effects on the sympathetic nervous system or on hemodynamic variables. Arch Intern Med (1983) 1.09
The Beirut terrorist bombing. Neurosurgery (1986) 1.07
In-vivo protection of group A beta-haemolytic streptococci from penicillin by beta-lactamase-producing Bacteroides species. J Antimicrob Chemother (1983) 1.05
Relationship of TXB2 and 6-keto PGF1 alpha to the hemodynamic changes during baboon endotoxic shock. Adv Prostaglandin Thromboxane Res (1980) 1.03
Cardiovascular performance with E. coli challenges in a canine model of human sepsis. Am J Physiol (1988) 1.02
Effect of antimicrobial therapy on bowel flora and bacterial infection in irradiated mice. Int J Radiat Biol Relat Stud Phys Chem Med (1988) 1.01
Pathogenicity of encapsulated Bacteroides melaninogenicus group, B. oralis and B. ruminicola subsp. brevis in abscesses in mice. J Infect (1983) 1.00
Disruption of the permeability barrier (zonula occludens) between intestinal epithelial cells by lethal doses of endotoxin. Infect Immun (1978) 0.99
Sympathetic nervous system "switch off" with severe hypothermia. Crit Care Med (1983) 0.99
Prospects for management of gastrointestinal injury associated with the acute radiation syndrome. Gastroenterology (1988) 0.99
Lidocaine or indomethacin improves survival in baboon endotoxin shock. J Surg Res (1978) 0.98
Aseptic endotoxemia in radiation injury and graft-vs-host diesease. Radiat Res (1975) 0.98
Pathogenicity of piliated and encapsulated Bacteroides fragilis. Eur J Clin Microbiol (1984) 0.97
Improved survival in the suckling rat model of group B streptococcal sepsis after treatment with nonsteroidal anti-inflammatory drugs. Pediatrics (1982) 0.94
Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial. Vaccine (2005) 0.94
Expression of Campylobacter genes for proline biosynthesis in Escherichia coli. Can J Microbiol (1985) 0.93
Infectivity of organisms recovered from polymicrobial abscesses. Infect Immun (1983) 0.93
Bubonic plague: detection of endotoxemia with the limulus test. Ann Intern Med (1973) 0.93
Diminished pressor response to exogenous norepinephrine and angiotensin II in septic, unanesthetized rats: evidence for a prostaglandin-mediated effect. J Surg Res (1985) 0.93
The role of prostaglandins in sepsis. Scand J Infect Dis Suppl (1982) 0.93
Eosinophil kinetics in two patients with eosinophilia. Blood (1970) 0.92
Prostaglandins and the hemodynamic course of endotoxin shock. J Surg Res (1976) 0.92
Thromboxane, prostacyclin, and hemodynamic events in primate endotoxin shock. Adv Shock Res (1981) 0.91
Suspected encephalomyocarditis virus infection in pigs. Aust Vet J (1970) 0.91
Automated fluorescent analysis procedure for enzymatic mutation detection. Clin Chem (1998) 0.91
Transitions among the myeloproliferative disorders. Ann Intern Med (1969) 0.90
The role of prostaglandins in endotoxemia: comparisons in response in the nonpregnant, maternal, and fetal models. I. Prostaglandins and the pulmonary effect of experimental endotoxemia. Am J Obstet Gynecol (1980) 0.90
The distribution of lipopolysaccharide in normocomplementemic and C3-depleted rabbits and rhesus monkeys. Am J Pathol (1980) 0.90
E. coli endotoxin shock in the dog; treatment with lidocaine or indomethacin. Br J Pharmacol (1978) 0.89
Prostaglandins in shock: to give or to block? Adv Shock Res (1980) 0.89
Role of zinc in the abatement of hepatocellular damage and mortality incidence in endotoxemic rats. Infect Immun (1977) 0.89
Prevention of endotoxin-induced pulmonary hypertension in primates by the use of a selective thromboxane synthetase inhibitor, OKY 1581. J Pharmacol Exp Ther (1982) 0.89
The effect of footrot on body weight and wool growth of sheep. Aust Vet J (1991) 0.89
Beneficial effect of indomethacin on acid-induced esophagitis in cats. Dig Dis Sci (1981) 0.88
Trehalose dimycolate enhances resistance to infection in neutropenic animals. Infect Immun (1989) 0.87
Indomethacin improves survival in gram-negative sepsis. Adv Shock Res (1981) 0.87
The effects of prostacyclin (PGI2) on endotoxin shock and endotoxin-induced platelet aggregation in dogs. Circ Shock (1980) 0.87
Significance of encapsulated Bacteroides melaninogenicus and Bacteroides fragilis groups in mixed infections. Infect Immun (1984) 0.87
Blood coagulation studies in Plasmodium falciparum malaria. Am J Med Sci (1973) 0.86
The contribution of intestinal endotoxin to mortality in hosts with compromised resistance: a review. Exp Hematol (1978) 0.86
Enteric disease program assesses health risks to naval personnel. US Navy Med (1981) 0.85
Rat intraperitoneal sepsis--a clinically relevant model. Circ Shock (1983) 0.84
Problems and priorities for controlling opportunistic pathogens with new antimicrobial strategies; an overview of current literature. Zentralbl Bakteriol (1996) 0.84
Plasma levels of 6-keto PGF1 alpha but not TxB2 increase in rats with peritonitis due to cecal ligation. Circ Shock (1985) 0.84
Vascular reactivity in endotoxin shock: effect of lidocaine or indomethacin pretreatment. Adv Shock Res (1982) 0.84
Development of a primate model of exposure hypothermia. Adv Shock Res (1983) 0.83
The role of encapsulation in the pathogenesis of anaerobic gram-positive cocci. Can J Microbiol (1985) 0.83
Endotoxin-induced alterations in canine granulopoiesis: colony-stimulating factor, colony-forming cells in culture, and growth of cells in diffusion chambers. Exp Hematol (1978) 0.83
In vitro and in vivo pathologic effects of Vibrio parahaemolyticus on human epithelial cells. Can J Microbiol (1984) 0.83
Plasma, urine, and CSF catecholamine concentrations during and after ketamine anesthesia. Crit Care Med (1982) 0.83
A PAF receptor antagonist, BN 52021, attenuates thromboxane release and improves survival in lethal canine endotoxemia. Circ Shock (1991) 0.82
The procoagulant activity of granulocytes. Proc Soc Exp Biol Med (1973) 0.82
Thromboxane inhibition in gram-negative sepsis fails to improve survival. Adv Prostaglandin Thromboxane Leukot Res (1983) 0.82
Possible association of mucous blanket integrity with postirradiation colonization resistance. Radiat Res (1985) 0.82
Relationship between Russian roulette deaths and risk-taking behavior: a controlled study. Am J Psychiatry (1987) 0.82
Indomethacin treatment following baboon endotoxin shock improves survival. Adv Shock Res (1980) 0.81
Pathogenicity of Clostridium species with other bacteria in mixed infections. J Infect (1986) 0.81
Neutrophil kinetics and the regulation of granulopoiesis. Rev Infect Dis (1980) 0.81
Disruption of the goblet cell intercellular junction following histamine infusion of the rabbit ileum. Experientia (1983) 0.81
E. coli endotoxin shock in the baboon: treatment with lidocaine or indomethacin. Adv Prostaglandin Thromboxane Res (1978) 0.81
Epinephrine absorption after intratracheal administration. Anesth Analg (1984) 0.80
Biologic properties of bacterial lipopolysaccharides treated with chromium chloride. Can J Microbiol (1978) 0.80
Current concepts in the management of radiation injuries and associated trauma. Surg Gynecol Obstet (1983) 0.80
Improved survival in endotoxemia with aspirin and indomethacin pretreatment. Surg Forum (1976) 0.80
Medullary (solid) carcinoma of the thyroid gland. A review of 249 cases. Arch Surg (1970) 0.80
Increased circulating plasma norepinephrine concentrations in noncardiac causes of pulmonary hypertension. Crit Care Med (1984) 0.80
Antibiotic decontamination of the dog and its consequences. Lab Anim Sci (1978) 0.80
Development and preclinical evaluation of a trivalent, formalin-inactivated Shigella whole-cell vaccine. Clin Vaccine Immunol (2014) 0.80
Hemorrhagic hypotension increases plasma beta-endorphin concentrations in the nonhuman primate. Crit Care Med (1986) 0.80